Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, November 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 101 articles:
HTML format


 

Single Articles

  1. DE BOER P, van de Schoot AJAJ, Westerveld H, Smit M, et al
    Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.
    Strahlenther Onkol. 2017 Nov 3. doi: 10.1007/s00066-017-1224.
    Abstract    

    Abstract available

  2. YANG SF, Liu YF, Cheng CW, Yang WE, et al
    Impact of microRNA-34a and polymorphism of its target gene CA9 on susceptibility to uterine cervical cancer.
    Oncotarget. 2017;8:77860-77871.
    Abstract    

    Abstract available

  3. FENG C, Ma F, Hu C, Ma JA, et al
    SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.
    Cell Cycle. 2017 Nov 3:1-34. doi: 10.1080/15384101.2017.1395533.
    Abstract    

    Abstract available

  4. SUN M, Cole AP, Lipsitz SL, Trinh QD, et al
    Trends in Breast, Colorectal, and Cervical Cancer Incidence Following the Affordable Care Act: Implications for Cancer Screening.
    JAMA Oncol. 2017 Nov 2. doi: 10.1001/jamaoncol.2017.3861.
    Abstract    



  5. JIANG L, Shi S, Shi Q, Zhang H, et al
    Similarity in the functions of HIF-1alpha and HIF-2alpha proteins in cervical cancer cells.
    Oncol Lett. 2017;14:5643-5651.
    Abstract    

    Abstract available

  6. FREDMAN E, Traughber B, Podder T, Colussi V, et al
    3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
    Brachytherapy. 2017 Oct 30. pii: S1538-4721(17)30465.
    Abstract    

    Abstract available

  7. FRENEL JS, Le Tourneau C, O'Neil B, Ott PA, et al
    Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.
    J Clin Oncol. 2017 Nov 2:JCO2017745471. doi: 10.1200/JCO.2017.74.5471.
    Abstract    

    Abstract available

  8. HARAO M, Ando J, Kamata H, Hoshi N, et al
    Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
    Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0813.
    Abstract    

    Abstract available

  9. LOPEZ MS, Baker ES, Milbourne AM, Gowen RM, et al
    Project ECHO: A Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource Settings.
    J Glob Oncol. 2016;3:658-665.
    Abstract    

    Abstract available

  10. JERONIMO J, Castle PE, Temin S, Denny L, et al
    Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.
    J Glob Oncol. 2016;3:635-657.
    Abstract    

    Abstract available

  11. ARROSSI S, Temin S, Garland S, Eckert LO, et al
    Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline.
    J Glob Oncol. 2017;3:611-634.
    Abstract    

    Abstract available

  12. WU ES, Jeronimo J, Feldman S
    Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.
    J Glob Oncol. 2017;3:572-582.
    Abstract    

    Abstract available

  13. ORANG'O E, Itsura P, Tonui P, Muliro H, et al
    Use of Palliative Cisplatinum for Advanced Cervical Cancer in a Resource-Poor Setting: A Case Series From Kenya.
    J Glob Oncol. 2016;3:539-544.
    Abstract    

    Abstract available

  14. CASTANON A, Landy R, Michalopoulos D, Bhudia R, et al
    Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries.
    J Glob Oncol. 2017;3:524-538.
    Abstract    

    Abstract available

  15. GOTTSCHLICH A, Rivera-Andrade A, Grajeda E, Alvarez C, et al
    Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala.
    J Glob Oncol. 2017;3:444-454.
    Abstract    

    Abstract available

  16. AMEMIYA T, Shibata K, Itoh Y, Itoh K, et al
    Primordial oscillations in life: Direct observation of glycolytic oscillations in individual HeLa cervical cancer cells.
    Chaos. 2017;27:104602.
    Abstract    

    Abstract available

  17. AMEMIYA T, Shibata K, Itoh Y, Itoh K, et al
    Publisher's Note: "Primordial oscillations in life: Direct observation of glycolytic oscillations in individual HeLa cervical cancer cells" [Choas 27, 104602 (2017)].
    Chaos. 2017;27:109901.
    Abstract    



  18. ZHANG Z, Wang J, Li J, Wang X, et al
    MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4.
    Biomed Pharmacother. 2017;97:511-517.
    Abstract    

    Abstract available

  19. TANG H, Wang Y, Zhang B, Xiong S, et al
    High brain acid soluble protein 1(BASP1) is a poor prognostic factor for cervical cancer and promotes tumor growth.
    Cancer Cell Int. 2017;17:97.
    Abstract    

    Abstract available

  20. ZHANG X, Wang Y, Cao Y, Zhang X, et al
    Increased CCL19 expression is associated with progression in cervical cancer.
    Oncotarget. 2017;8:73817-73825.
    Abstract    

    Abstract available

  21. REES HD, Lombardo AR, Tangoren CG, Meyers SJ, et al
    Knowledge and beliefs regarding cervical cancer screening and HPV vaccination among urban and rural women in Leon, Nicaragua.
    PeerJ. 2017;5:e3871.
    Abstract    

    Abstract available

  22. BECKER AS, Ghafoor S, Marcon M, Perucho JA, et al
    MRI texture features may predict differentiation and nodal stage of cervical cancer: a pilot study.
    Acta Radiol Open. 2017;6:2058460117729574.
    Abstract    

    Abstract available

  23. SUN X, Liu Y
    Activation of the Wnt/beta-catenin signaling pathway may contribute to cervical cancer pathogenesis via upregulation of Twist.
    Oncol Lett. 2017;14:4841-4844.
    Abstract    

    Abstract available

  24. LV X, Hou M, Duan X
    Correlation analysis between the parameters of contrast-enhanced ultrasonography in evaluating cervical cancer metastasis and expression of E-cadherin.
    Oncol Lett. 2017;14:4641-4646.
    Abstract    

    Abstract available

  25. STIASNY A, Freier CP, Kuhn C, Schulze S, et al
    The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer.
    Oncol Lett. 2017;14:4467-4476.
    Abstract    

    Abstract available

  26. CAROW K, Read C, Hafner N, Runnebaum IB, et al
    A comparative study of digital PCR and real-time qPCR for the detection and quantification of HPV mRNA in sentinel lymph nodes of cervical cancer patients.
    BMC Res Notes. 2017;10:532.
    Abstract    

    Abstract available

  27. PELLEGRINO A, Damiani GR, Loverro M, Pirovano C, et al
    Comparison of Robotic and laparoscopic Radical type-B and C hysterectomy for cervical cancer: Long term-outcomes.
    Acta Biomed. 2017;88:289-296.
    Abstract    

    Abstract available

  28. KWON J, Eom KY, Kim YS, Park W, et al
    The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).
    Cancer Res Treat. 2017 Oct 24. doi: 10.4143/crt.2017.
    Abstract    

    Abstract available

  29. DARRE T, Aboubakari AS, N'Bortche BK, Bassowa A, et al
    Association of Schistosomiasis with Cervical Cancer in Togo: the Consequence of this Association.
    Pathol Oncol Res. 2017 Oct 27. doi: 10.1007/s12253-017-0350.
    Abstract    

    Abstract available

  30. VARGHESE VK, Shukla V, Kabekkodu SP, Pandey D, et al
    DNA Methylation Regulated microRNAs in Human Cervical Cancer.
    Mol Carcinog. 2017 Oct 27. doi: 10.1002/mc.22761.
    Abstract    

    Abstract available

  31. ZHOU YM, Freese C, Meier T, Go D, et al
    The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation.
    Clin Transl Oncol. 2017 Oct 26. doi: 10.1007/s12094-017-1771.
    Abstract    

    Abstract available

  32. DEGU A, Njogu P, Weru I, Karimi P, et al
    Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya.
    Gynecol Oncol Res Pract. 2017;4:15.
    Abstract    

    Abstract available

  33. ASERLIND A, Maguire K, Duthely L, Wennin S, et al
    Women Living with HIV over Age of 65: Cervical Cancer Screening in a Unique and Growing Population.
    Infect Dis Obstet Gynecol. 2017;2017:2105061.
    Abstract    

    Abstract available

  34. DONG P, Xiong Y, Hanley SJB, Yue J, et al
    Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
    J Exp Clin Cancer Res. 2017;36:150.
    Abstract    

    Abstract available

  35. LUO HC, Lin GS, Liao SG, Wang FM, et al
    Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS. RTOG).
    Br J Radiol. 2017 Oct 26:20170398. doi: 10.1259/bjr.20170398.
    Abstract    

    Abstract available

  36. YOSHIHIRO U, Shingo O, Masaru I, Masayoshi M, et al
    Strategies for reducing ovarian dose in volumetric modulated arc therapy (VMAT) for postoperative uterine cervical cancer.
    Br J Radiol. 2017 Nov 3:20160777. doi: 10.1259/bjr.20160777.
    Abstract    

    Abstract available

  37. AL-RIFAI RH, Loney T
    Factors Associated with a Lack of Knowledge of Performing Breast Self-Examination and Unawareness of Cervical Cancer Screening Services: Evidence from the 2015 Egypt Health Issues Survey
    Asian Pac J Cancer Prev. 2017;18:2763-2769.
    Abstract    

    Abstract available

  38. CHEN L, Liu L, Li Y, Gao J, et al
    Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK/Parkin/mitophagy axis.
    In Vitro Cell Dev Biol Anim. 2017 Oct 25. doi: 10.1007/s11626-017-0200.
    Abstract    

    Abstract available

  39. WANG KD, Xu DJ, Wang BY, Yan DH, et al
    Inhibitory Effect of Vaginal Lactobacillus Supernatants on Cervical Cancer Cells.
    Probiotics Antimicrob Proteins. 2017 Oct 25. doi: 10.1007/s12602-017-9339.
    Abstract    

    Abstract available

  40. TSHOMO U, Franceschi S, Tshokey T, Tobgay T, et al
    Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan.
    Oncotarget. 2017;8:72438-72446.
    Abstract    

    Abstract available

  41. WANG X, Yi Y, Lv Q, Zhang J, et al
    Novel 1,3,5-Triazine Derivatives Exert Potent Anti-cervical Cancer Effects by Modulating Bax, Bcl2, and Caspases Expression.
    Chem Biol Drug Des. 2017 Oct 25. doi: 10.1111/cbdd.13133.
    Abstract    

    Abstract available

  42. WEAVER J, Harmon G, Harkenrider MM, Surucu M, et al
    Delineating the relationship between Point A prescription dose and pelvic lymph node doses in intracavitary high-dose-rate brachytherapy treatment of cervical cancer for use in low- and middle-income countries.
    Brachytherapy. 2017 Oct 21. pii: S1538-4721(17)30457.
    Abstract    

    Abstract available

  43. RAJAGOPALAN D, Pandey AK, Xiuzhen MC, Lee KK, et al
    TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.
    PLoS Pathog. 2017;13:e1006681.
    Abstract    

    Abstract available

  44. SOTO DR, Barton C, Munger K, McLaughlin-Drubin ME, et al
    KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress.
    PLoS Pathog. 2017;13:e1006661.
    Abstract    

    Abstract available

  45. FELHI S, Chaaibia M, Bakari S, Mansour RB, et al
    Anti-microbial screening and cytotoxic activity of aerial part of Thymelaea hirsuta L. essential oil growing in south-west Tunisia.
    Pak J Pharm Sci. 2017;30:87-91.
    Abstract    

    Abstract available

  46. NASH S, Bartels H, Pemberton J
    Metastatic cervical adenocarcinoma to the orbital subperiosteal space.
    Can J Ophthalmol. 2017;52:e60-e62.
    Abstract    



  47. KOLBEN TM, Bergauer F, Moeckel J, Boettcher B, et al
    Short interval between two Pap smears: effect on the result of the second smear? A prospective randomized trial.
    Arch Gynecol Obstet. 2017;295:1427-1433.
    Abstract    

    Abstract available

  48. LIU J, Fan H, Qiu GP
    Vascular permeability determined using multi-slice spiral CT perfusion can predict response to chemoradiotherapy in patients with advanced cervical squamous cell carcinoma.
    Int J Clin Pharmacol Ther. 2017;55:619-626.
    Abstract    

    Abstract available

  49. KUHN L, Denny L
    The time is now to implement HPV testing for primary screening in low resource settings.
    Prev Med. 2017;98:42-44.
    Abstract    

    Abstract available

  50. MAZA M, Gage JC
    Considerations for HPV primary screening in lower-middle income countries.
    Prev Med. 2017;98:39-41.
    Abstract    

    Abstract available

  51. TOWNSEND JS, Steele CB, Hayes N, Bhatt A, et al
    Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program.
    J Womens Health (Larchmt). 2017;26:200-206.
    Abstract    

    Abstract available

  52. AGENOR M, Muzny CA, Schick V, Austin EL, et al
    Sexual orientation and sexual health services utilization among women in the United States.
    Prev Med. 2017;95:74-81.
    Abstract    

    Abstract available

  53. ROYCHOWDHURY A, Samadder S, Das P, Mandloi S, et al
    Integrative genomic and network analysis identified novel genes associated with the development of advanced cervical squamous cell carcinoma.
    Biochim Biophys Acta. 2017;1861.
    Abstract    

    Abstract available

  54. EKWUNIFE OI, O'Mahony JF, Gerber Grote A, Mosch C, et al
    Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.
    Pharmacoeconomics. 2017;35:65-82.
    Abstract    

    Abstract available

  55. YU JS, Lee D, Lee SR, Lee JW, et al
    Chemical characterization of cytotoxic indole acetic acid derivative from mulberry fruit (Morus alba L.) against human cervical cancer.
    Bioorg Chem. 2017;76:28-36.
    Abstract    

    Abstract available

  56. NGUYEN AD, Hoang MV, Nguyen CC
    Medical costs for the treatment of cervical cancer at central hospitals in Vietnam.
    Health Care Women Int. 2017 Nov 10:0. doi: 10.1080/07399332.2017.1402912.
    Abstract    

    Abstract available

  57. SILVER MI, Rositch AF, Phelan-Emrick DF, Gravitt PE, et al
    Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.
    Cancer Causes Control. 2017 Nov 9. doi: 10.1007/s10552-017-0976.
    Abstract    

    Abstract available

  58. SY AU, Hernandez BY, Tareg A, Reichhardt M, et al
    Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
    Cancer Epidemiol. 2017;50.
    Abstract    

    Abstract available

  59. SENKOMAGO V, Royalty J, Miller JW, Buenconsejo-Lum LE, et al
    Cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in four US-Affiliated Pacific Islands between 2007 and 2015.
    Cancer Epidemiol. 2017;50.
    Abstract    

    Abstract available

  60. TESTA AC, Moro F, Pasciuto T, Moruzzi MC, et al
    Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultras
    Ultrasound Obstet Gynecol. 2017 Nov 8. doi: 10.1002/uog.18953.
    Abstract    

    Abstract available

  61. AKINFOLARIN AC, Olusegun AK, Omoladun O, Omoniyi-Esan GO, et al
    Age and Pattern of Pap Smear Abnormalities: Implications for Cervical Cancer Control in a Developing Country.
    J Cytol. 2017;34:208-211.
    Abstract    

    Abstract available

  62. CHEN G, Huang P, Xie J, Li R, et al
    microRNA211 suppresses the growth and metastasis of cervical cancer by directly targeting ZEB1.
    Mol Med Rep. 2017 Nov 7. doi: 10.3892/mmr.2017.8006.
    Abstract    

    Abstract available

  63. SHRESTHA S, Dhakal P
    Knowledge, Attitude and Practice Regarding Cervical Cancer Screening Among Women Attending a Teaching Hospital, Bharatpur, Chitwan.
    J Family Reprod Health. 2017;11:18-23.
    Abstract    

    Abstract available

  64. WINER RL, Tiro JA, Miglioretti DL, Thayer C, et al
    Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
    Contemp Clin Trials. 2017 Nov 4. pii: S1551-7144(17)30453.
    Abstract    

    Abstract available

  65. KIM HS, Kim R, Lee M
    Super-radical hysterectomy for recurrent cervical cancer.
    Surg Oncol. 2017;26:331-332.
    Abstract    

    Abstract available

  66. LIU GF, Zhang SH, Li XF, Cao LY, et al
    Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1.
    Oncotarget. 2017;8:80757-80769.
    Abstract    

    Abstract available

  67. SHI WJ, Liu H, Wu D, Tang ZH, et al
    E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.
    Oncol Lett. 2017;14:6251-6258.
    Abstract    

    Abstract available

  68. WYMANN MN, Zographos AS, Altpeter E, Spicher VM, et al
    Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey.
    Int J Public Health. 2017 Nov 6. doi: 10.1007/s00038-017-1050.
    Abstract    

    Abstract available

  69. PAPPA KI, Kontostathi G, Makridakis M, Lygirou V, et al
    High Resolution Proteomic Analysis of the Cervical Cancer Cell Lines Secretome Documents Deregulation of Multiple Proteases.
    Cancer Genomics Proteomics. 2017;14:507-521.
    Abstract    

    Abstract available

  70. MOSS JL, Liu B, Feuer EJ
    Urban/Rural Differences in Breast and Cervical Cancer Incidence: The Mediating Roles of Socioeconomic Status and Provider Density.
    Womens Health Issues. 2017 Nov 3. pii: S1049-3867(17)30093.
    Abstract    

    Abstract available

  71. CHI S, Shen L, Hua T, Liu S, et al
    Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:79061-79072.
    Abstract    

    Abstract available

  72. FAROOQUI A, Khan F, Khan I, Ansari IA, et al
    Glycyrrhizin induces reactive oxygen species-dependent apoptosis and cell cycle arrest at G0/G1 in HPV18+ human cervical cancer HeLa cell line.
    Biomed Pharmacother. 2017;97:752-764.
    Abstract    

    Abstract available

  73. DE VRIES HJC, Steenbergen RDM
    The effect of ART on cervical cancer precursor lesions.
    Lancet HIV. 2017 Oct 26. pii: S2352-3018(17)30189.
    Abstract    



  74. KELLY H, Weiss HA, Benavente Y, de Sanjose S, et al
    Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
    Lancet HIV. 2017 Oct 26. pii: S2352-3018(17)30149.
    Abstract    

    Abstract available

  75. TAO J, Dai J, Hou S
    Association between B7-H1 and cervical cancer: B7-H1 impairs the immune response in human cervical cancer cells.
    Exp Ther Med. 2017;14:4125-4133.
    Abstract    

    Abstract available

  76. HAWKES D, Brotherton JML, Saville M
    Concordant testing results between various Human Papillomavirus assays in primary cervical cancer screening.
    Clin Microbiol Infect. 2017 Nov 2. pii: S1198-743X(17)30596.
    Abstract    



  77. WANG P, Thapa D, Wu G, Sun Q, et al
    A study on diffusion and kurtosis features of cervical cancer based on non-Gaussian diffusion weighted model.
    Magn Reson Imaging. 2017 Nov 2. pii: S0730-725X(17)30241.
    Abstract    

    Abstract available

  78. ASSAD DX, Borges GA, Avelino SR, Guerra ENS, et al
    Additive cytotoxic effects of radiation and mTOR inhibitors in a cervical cancer cell line.
    Pathol Res Pract. 2017 Nov 2. pii: S0344-0338(17)30883.
    Abstract    

    Abstract available

  79. LEVY T
    The importance of HPV testing for cervical cancer screening in Israel.
    Isr Med Assoc J. 2017;19:644-465.
    Abstract    



  80. WU DM, Shi J, Liu T, Deng SH, et al
    Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
    Cancer Biomark. 2017 Oct 19. doi: 10.3233/CBM-170501.
    Abstract    

    Abstract available

  81. SIMHA V, Rai B, Patel FD, Kapoor R, et al
    Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
    Brachytherapy. 2017 Nov 1. pii: S1538-4721(17)30466.
    Abstract    

    Abstract available

  82. YAMASAKI T, Yanishi K, Tateishi S, Nakanishi N, et al
    Late-onset Mitochondrial Cardiomyopathy Triggered by Anticancer Treatment.
    Intern Med. 2017;56:1357-1361.
    Abstract    

    Abstract available

  83. HEINLEN L, Chakravarty EF
    Reproductive Health Screening in Women with Autoimmune Diseases.
    Rheum Dis Clin North Am. 2017;43:161-171.
    Abstract    

    Abstract available

  84. LI X, Huang H, Guan Y, Gong Y, et al
    Whole-exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women.
    Cancer Med. 2017;6:207-219.
    Abstract    

    Abstract available

  85. POSSATI-RESENDE JC, Vazquez FL, Biot ST, Mauad EC, et al
    Organized Cervical Cancer Screening Program in Barretos, Brazil: Experience in 18 Municipalities of Sao Paulo State.
    Acta Cytol. 2017 Oct 26. doi: 10.1159/000480446.
    Abstract    

    Abstract available

  86. MARKOVINA S, Wang S, Henke LE, Luke CJ, et al
    Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Br J Cancer. 2017 Nov 7. doi: 10.1038/bjc.2017.
    Abstract    

    Abstract available

  87. SONG KH, Choi CH, Lee HJ, Oh SJ, et al
    HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
    Cancer Res. 2017;77:5039-5053.
    Abstract    

    Abstract available

  88. PAYEN VL, Hsu MY, Radecke KS, Wyart E, et al
    Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter.
    Cancer Res. 2017;77:5591-5601.
    Abstract    

    Abstract available

  89. NING MS, Ahobila V, Jhingran A, Stecklein SR, et al
    Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.
    Gynecol Oncol. 2017 Oct 28. pii: S0090-8258(17)31420.
    Abstract    

    Abstract available

  90. LAAN JJ, van Lonkhuijzen LRCW, van Os RM, Tytgat KM, et al
    Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer.
    Gynecol Oncol. 2017 Oct 23. pii: S0090-8258(17)31416.
    Abstract    

    Abstract available

  91. SPAANS VM, Nyoman Bayu Mahendra I, Purwoto G, Trietsch MD, et al
    The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31369.
    Abstract    

    Abstract available

  92. LEE JH, Lee SW, Kim JR, Kim YS, et al
    Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
    Gynecol Oncol. 2017 Oct 27. pii: S0090-8258(17)31360.
    Abstract    

    Abstract available

  93. BAUER-NILSEN K, Hill C, Trifiletti DM, Libby B, et al
    Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2017 Sep 14. pii: S0360-3016(17)33855.
    Abstract    

    Abstract available

  94. LIM-REINDERS S, Keller BM, Al-Ward S, Sahgal A, et al
    Online Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:994-1003.
    Abstract    

    Abstract available

  95. KOK HP, Korshuize-van Straten L, Bakker A, de Kroon-Oldenhof R, et al
    Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots.
    Int J Radiat Oncol Biol Phys. 2017;99:1039-1047.
    Abstract    

    Abstract available

  96. KAMPHUIS EI, Naber SK, Danhof NA, Habbema JDF, et al
    Effect of Cervical Cancer Screening Programs on Preterm Birth: A Decision and Cost-Effectiveness Analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002366.
    Abstract    

    Abstract available

  97. CORTESSIS VK, Barrett M, Brown Wade N, Enebish T, et al
    Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002307.
    Abstract    

    Abstract available

  98. LI S, Wen X
    Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999-2014).
    BMC Cancer. 2017;17:726.
    Abstract    

    Abstract available

  99. WANG J, Andrae B, Sundstrom K, Ploner A, et al
    Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    PLoS Med. 2017;14:e1002414.
    Abstract    

    Abstract available

  100. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    Abstract    

    Abstract available

  101. SPURGEON ME, den Boon JA, Horswill M, Barthakur S, et al
    Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.
    Proc Natl Acad Sci U S A. 2017;114:E9076-E9085.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;